Iodine(III)-Mediated Radiofluorination
US-2016362375-A1 · Dec 15, 2016 · US
US9957231B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9957231-B2 |
| Application number | US-201615231470-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 8, 2016 |
| Priority date | Mar 7, 2014 |
| Publication date | May 1, 2018 |
| Grant date | May 1, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A process for fluorination of aromatic compounds employing iodonium ylides and applicable to radiofluorination using 18 F is described. Processes, intermediates, reagents and radiolabelled compounds are described.
Opening claim text (preview).
What is claimed is: 1. A process for fluorodeiodination of an aromatic iodide compound comprising: (a) oxidizing an aromatic iodide compound (Ar-I), to form an iodonium compound; (b) reacting the iodonium compound with a compound of formula (A): to form an iodonium ylide; (c) reacting the iodonium ylide with a fluoride source to form an aromatic fluoride compound (Ar-F); wherein: R A and R B in combination, together with the carbon atom to which R A and R B are attached, form a 3, 4, 5, 6, or 7-membered carbocyclic or a heterocyclic ring containing 3 to 7 carbon atoms and 0, 1, or 2 ring heteroatoms, each independently selected from N, O, and S, wherein the ring formed by the combination of R A and R B is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 1-6 hydroxyalkyl, and oxo. 2. The process of claim 1 , wherein step (a) is performed in the presence of an oxidizing agent selected from the group consisting of sodium perborate, urea-hydrogen peroxide adduct, 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (Selectfluor®), potassium peroxymonosulfate (OXONE®), dimethyldioxirane, or meta-chloroperoxybenzoic acid. 3. The process of claim 2 , wherein step (a) is performed in the presence of a carboxylate source that is an acetate source or trifluoroacetate source. 4. The process of claim 1 , wherein said iodonium product of step (a) is an iodonium compound of Formula B or Formula C: wherein Ar is an aromatic group, wherein Ar is connected to the iodonium group through an aromatic ring carbon atom. 5. The process of claim 1 , wherein step (b) is carried out in the presence of a base. 6. The process of claim 1 , wherein said iodonium ylide formed in step (b) is an iodonium ylide of Formula D: wherein Ar is an aromatic group, wherein Ar is connected to the iodonium group through an aromatic ring carbon atom. 7. The process of claim 1 , wherein the compound of Formula A is a compound of the following formula: 8. The process of claim 1 , wherein the compound of Formula A is a compound of the following formula: 9. The process of claim 1 , comprising isolating or purifying the iodonium ylide following step (b). 10. The process of claim 1 , wherein said fluoride source of step (c) is a fluoride salt. 11. The process of claim 1 , wherein said fluoride source comprises [ 18 F] fluoride. 12. The process of claim 11 , wherein said fluoride source is tetraethylammonium [ 18 F]fluoride. 13. A compound of Formula D: wherein: Ar is an aromatic group; and R A and R B in combination, together with the carbon atom to which R A and R B are attached, form a 3, 4, 5, 6, or 7-membered carbocyclic or a heterocyclic ring containing 3 to 7 carbon atoms and 0, 1, or 2 ring heteroatoms, each independently selected from N, O, and S, wherein the ring formed by the combination of R A and R B is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 1-6 hydroxyalkyl, and oxo; and wherein Ar is connected to the iodonium group through an aromatic ring carbon atom. 14. The compound of claim 13 , wherein the compound of Formula D is a compound of the following formula: 15. The compound of claim 13 , wherein the compound of Formula D is a compound of the following formula: 16. A process for preparing a compound according to claim 13 comprising: (a) oxidizing an aromatic iodide compound (Ar-I), to form an iodonium compound; (b) reacting the iodonium compound with a compound of formula (A): wherein Z 1 , Z 2 , R A and R B are as defined in claim 13 , to form a compound according to claim 13 . 17. A process for preparing an aromatic fluoride compound (Ar-F) comprising (c) reacting a compound according to claim 13 with a fluoride source to form an aromatic fluoride compound. 18. The process of claim 17 , wherein said fluoride source of step (c) is a fluoride salt. 19. The process of claim 17 , wherein said fluoride source comprises [ 18 F] fluoride. 20. The process of claim 19 , wherein said fluoride source is tetraethylammonium [ 18 F]fluoride. 21. The process of claim 1 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached, form a 3, 4, 5, 6, or 7-membered carbocyclic ring, wherein the ring formed by the combination of R A and R B is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 1-6 hydroxyalkyl, and oxo. 22. The compound of claim 13 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached, form a 3, 4, 5, 6, or 7-membered carbocyclic ring, wherein the ring formed by the combination of R A and R B is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 1-6 hydroxyalkyl, and oxo. 23. The process of claim 1 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached form a cyclobutyl, cyclopentyl, or cyclohexyl ring. 24. The compound of claim 13 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached form a cyclobutyl, cyclopentyl, or cyclohexyl ring. 25. The process of claim 1 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached form a cyclopentyl ring. 26. The compound of claim 13 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached form a cyclopentyl ring. 27. The process of claim 1 , wherein the compound of Formula A is a compound of the following formula: 28. The compound of claim 13 , wherein the compound of Formula D is a compound of the following formula:
with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil · CPC title
substituted in position 17 by a keto group · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton (cardanolide, bufanolide C07J19/00) · CPC title
not condensed with other rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.